Sourcebio International (LON:SBI) Trading Up 4.5% – Here’s Why

Sourcebio International Plc (LON:SBI)’s share price rose 4.5% during mid-day trading on Thursday . The company traded as high as GBX 125 ($1.57) and last traded at GBX 115 ($1.45). Approximately 1,571,282 shares traded hands during trading, an increase of 931% from the average daily volume of 152,444 shares. The stock had previously closed at GBX 110 ($1.38).

Sourcebio International Price Performance

The company’s 50-day simple moving average is GBX 115 and its 200 day simple moving average is GBX 115. The company has a market cap of £85.31 million and a PE ratio of 1,277.78. The company has a debt-to-equity ratio of 35.10, a quick ratio of 1.78 and a current ratio of 1.91.

Sourcebio International Company Profile

Sourcebio International Plc, together with its subsidiaries, provides various laboratory services and products to clients in the healthcare, clinical, life science research, and biopharma industries in the United Kingdom, Europe, the United States, and internationally. The company's services cover histopathology cancer screening and clinical diagnostic services; DNA sequencing services and precision medicine to pharmaceutical and biotechnology companies, academia, contract research organizations, and other research markets; shelf-life testing services and equipment; and COVID-19 antigen PCR testing services.